Texas A&M Rangel College of Pharmacy researcher receives a grant from the FDA to develop a test method for finding therapeutic equivalency of topical eye medications. The test method will show whether the medication is equally effective in both the brand and generic formulations. It will also reduce the amount of time and money required for a generic medication to reach the pharmacy shelf.
The Texas A&M Health Science Center brings together scientists across Texas in a multi-institutional academic drug discovery program. With the help of state-of-the-art equipment, the consortium aims to repurpose drugs to treat devastating illnesses, a process that costs a fraction of the time and money it takes to develop an entirely new drug.